Probiotic Preparation Containing Akk11 Strain for Calcium Absorption
Summary
USPTO published patent application US20260109939A1, filed June 19, 2024 under application no. 18995236, disclosing a probiotic preparation combining Akkermansia muciniphila Akk11 strain and Bifidobacterium breve BBr16 strain designed to synergistically enhance calcium absorption by improving intestinal health and strengthening the absorption capacity of the intestinal wall. The application claims the preparation can promote serum calcium and phosphorus levels, restore normal electrolyte levels, and reduce calcium loss in bones to stabilize bone structure and function. This is the initial publication of the patent application — no patent has yet been granted.
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 227 changes logged to date.
What changed
USPTO published patent application US20260109939A1 for a probiotic preparation combining Akkermansia muciniphila Akk11 and Bifidobacterium breve BBr16 strains, claiming synergistic enhancement of calcium absorption through improved intestinal health and enhanced intestinal wall absorption capacity. The application further claims promotion of serum calcium and phosphorus levels, restoration of normal electrolyte balance, and reduction of calcium loss from bones. CPC classifications include C12N 1/20 and A61P 3/14, with six named inventors including Shuguang Fang and Jianguo Zhu. No patent has been granted — this is a published application stage document.
Functional food manufacturers, dietary supplement producers, and pharmaceutical companies developing calcium-related or gut-health products should monitor this filing as it matures through the examination process. If granted, the broad combinatorial claims covering Akk11 with BBr16 for calcium absorption could affect freedom-to-operate analyses for competing probiotic and supplement products targeting bone health or mineral absorption.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PROBIOTIC PREPARATION CONTAINING AKK11 STRAIN FOR PROMOTING CALCIUM ABSORPTION AND USE THEREOF
Application US20260109939A1 Kind: A1 Apr 23, 2026
Inventors
Shuguang FANG, Yao DONG, Jiayue GU, Zhiyi WU, Zhonghui GAI, Jianguo ZHU
Abstract
Provided are a probiotic preparation containing an Akk11 strain for promoting calcium absorption and a use thereof, and the probiotic preparation for promoting calcium absorption includes an Akkermansia muciniphila Akk11 strain and a Bifidobacterium breve BBr16 strain. The present application developed a novel compounding method for probiotics, and found potential interactions between the Akk11 strain and BBr16 strain that these two strains can cooperate with each other to synergistically enhance the effect of promoting calcium absorption, specifically manifested in: the overall metabolism ability of calcium can be improved through the improvement of intestinal health and the enhancement of the absorption capacity of the intestinal wall; the serum calcium level and phosphorus content can be promoted and restore a normal electrolyte level; and the loss of calcium in bones can be effectively reduced, thereby stabilizing the structure and function of the bones.
CPC Classifications
C12N 1/20 A61P 3/14 A61K 2035/11 C12R 2001/01
Filing Date
2024-06-19
Application No.
18995236
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.